_PRIVATE_LIMITED.webp)
Proteogen Biosciences (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.20 M
- Company Age 13 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 13.14 Cr
- Satisfied Charges ₹ 1.89 Cr
- Revenue Growth -3.61%
- Profit Growth -18.97%
- Ebitda -9.88%
- Net Worth 24.15%
- Total Assets 37.73%
About Proteogen Biosciences (India)
Proteogen Biosciences (India) Private Limited (PBIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 31 May 2011 and has a history of 13 years and seven months. Its registered office is in Bangalore, Karnataka, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹13.14 Cr. The company has closed loans amounting to ₹1.89 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ganesh Vsrinivasan, Srinivasan Vadakkanthara, Aruna Krishna, and Three other members serve as directors at the Company.
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51109KA2011PTC058876
- Company No.
058876
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Proteogen Biosciences (India)?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganesh Vsrinivasan  | Whole-Time Director | 31-May-2011 | Current |
| Srinivasan Vadakkanthara | Whole-Time Director | 31-May-2011 | Current |
| Aruna Krishna | Director | 26-Mar-2012 | Current |
| Sridhar Reddy | Director | 26-Mar-2012 | Current |
| Mahesh Krishnareddy | Director | 03-Feb-2022 | Current |
| Krishnamoorthy Sharadha | Director | 03-Feb-2022 | Current |
Financial Performance of Proteogen Biosciences (India).
Proteogen Biosciences (India) Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.61% decrease. The company also saw a substantial fall in profitability, with a 18.97% decrease in profit. The company's net worth Soared by an impressive increase of 24.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Proteogen Biosciences (India)?
In 2023, Proteogen Biosciences (India) had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Proteogen Biosystems (I) Private LimitedGanesh Vsrinivasan and Sridhar Reddy are mutual person
Charges (Loans)
₹131.42 M
₹18.91 M
Charges Breakdown by Lending Institutions
- Others : 13.14 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Jan 2018 | Others | ₹13.14 Cr | Open |
| 23 May 2019 | Others | ₹1.64 Cr | Satisfied |
| 29 Dec 2013 | Kotak Mahindra Bank Limited | ₹2.50 M | Satisfied |
How Many Employees Work at Proteogen Biosciences (India)?
Unlock and access historical data on people associated with Proteogen Biosciences (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Proteogen Biosciences (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Proteogen Biosciences (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
